1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 2:Average MD and FA values of ROIs from patients with RNMO and control subjects
ROI Average MD (×10−3 mm2 s−1) Average FA RNMO Controls P* (95% CI) RNMO Controls P* (95% CI) Medulla oblongata 1.271 ± 0.111 1.111 ± 0.102 <.001 0.266 ± 0.014 0.287 ± 0.026 .005 (1.212–1.330) (1.057–1.165) (0.084 to 0.237) (0.259–0.274) (0.275–0.300) (−0.035 to −0.007) Cerebral peduncle 1.007 ± 0.111 0.872 ± 0.053 <.001 0.489 ± 0.035 0.535 ± 0.024 <.001 (0.948–1.066) (0.843–0.900) (0.072 to 0.198) (0.471–0.508) (0.522–0.548) (−0.067 to −0.024) Internal capsule 0.735 ± 0.010 0.718 ± 0.011 <.001 0.661 ± 0.019 0.693 ± 0.022 <.001 (0.730–0.741) (0.712–0.723) (0.010 to 0.065) (0.651–0.671) (0.681–0.705) (−0.047 to −0.017) Optic radiation 0.876 ± 0.033 0.824 ± 0.031 <.001 0.527 ± 0.039 0.585 ± 0.030 <.001 (0.859–0.894) (0.808–0.840) (−0.076 to −0.029) (0.506–0.547) (0.569–0.601) (−0.083 to −0.033) Splenium of corpus callosum 0.759 ± 0.034 0.726 ± 0.033 .009 0.815 ± 0.034 0.817 ± 0.033 .846 (0.741–0.777) (0.708–0.743) (0.009 to 0.057) (0.796–0.833) (0.799–0834) (−0.027 to 0.022) Genu of corpus callosum 0.765 ± 0.049 0.731 ± 0.038 .033 0.832 ± 0.033 0.829 ± 0.020 .741 (0.739–0.794) (0.711–0.751) (0.003 to 0.066) (0.814–0.849) (0.818–0.839) (−0.016 to 0.023) Putamen 0.729 ± 0.012 0.721 ± 0.011 .068 (0.722–0.735) (0.715–0.727) (−0.001 to 0.016) Thalamus 0.775 ± 0.022 0.760 ± .025 .066 (0.763–0.786) (0.746–0.772) (−0.001 to 0.032) Frontal gray matter 0.674 ± 0.042 0.634 ± 0.050 .023 (0.651–0.696) (0.608–0.661) (0.006 to 0.073) Parietal gray matter 0.807 ± 0.014 0.779 ± 0.016 <.001 (0.800–0.814) (0.771–0.788) (0.017 to 0.038) Temporal gray matter 0.838 ± 0.020 0.823 ± 0.011 .016 (0.827–0.849 (0.818–0.829) (0.003 to 0.026) Occipital gray matter 0.780 ± 0.012 0.758 ± 0.016 .007 (0.770–0.790) (0.746–0.770) (0.006 to 0.036)
Note:—RNMO indicates relapsing neuromyelitis optica; MD, mean diffusivity; FA, fractional anisotropy; ROI, region of interest. Values are expressed as mean ± SD (95% confidence interval).
* Statistical analysis: Student t test for independent samples; P < .005 is considered significant.